Investigation of indolamine 2, 3 dioxygenase ( IDO‐1 ) gene expression by real‐time PCR among patients with lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Investigation of indolamine 2, 3 dioxygenase ( IDO‐1 ) gene expression by real‐time PCR among patients with lung cancer

Published:2019-01-22 Issue:8 Volume:234 Page:13781-13787
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Haji Mazdarani Mojtaba¹^ORCID,Jafarikia Milad²,Nemati Fahimeh³

Affiliation:

1. Department of Microbiology Islamic Azad University of Varamin Pishva Iran

2. Department of Genetic Islamic Azad University of Varamin Pishva Iran

3. Department of Biotechnology Faculty of Advanced Sciences and Technology, Pharmaceutical Sciences Branch, Islamic Azad University Tehran Iran

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.28057

Reference23 articles.

1. Prognostic value of indoleamine 2,3-dioxygenase activity and expression in nasopharyngeal carcinoma

2. Analysis of Indoleamine 2-3 Dioxygenase (IDO) and EGFR Co-expression in Breast Cancer Tissue by Immunohistochemistry

3. Gamma Interferon Fails To Induce Expression of Indoleamine 2,3-Dioxygenase and Does Not Control the Growth of Chlamydophila abortus in BeWo Trophoblast Cells

4. Immune resistance orchestrated by the tumor microenvironment

5. Tolerance, DCs and tryptophan: much ado about IDO

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-target inhibitors of indoleamine 2, 3 dioxygenase 1 (Ido1): A promising direction in cancer immunotherapy;European Journal of Medicinal Chemistry;2022-08

2. Mechanism of miR-760 Reversing Lung Cancer Immune Escape by Downregulating IDO1 and Eliminating Regulatory T Cells Based on Mathematical Biology;Computational and Mathematical Methods in Medicine;2022-07-14

3. IDO1 plays a tumor-promoting role via MDM2-mediated suppression of the p53 pathway in diffuse large B-cell lymphoma;Cell Death & Disease;2022-06-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3